Journal article
Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials
Abstract
Background:Objectives were to compare systemic mould-active vs fluconazole prophylaxis in cancer patients receiving chemotherapy or haematopoietic stem cell transplantation (HSCT).Methods:We searched OVID MEDLINE and the Cochrane Central Register of Controlled Trials (1948-August 2011) and EMBASE (1980-August 2011). Randomised controlled trials of mould-active vs fluconazole prophylaxis in cancer or HSCT patients were included. Primary outcome …
Authors
Ethier MC; Science M; Beyene J; Briel M; Lehrnbecher T; Sung L
Journal
British Journal of Cancer, Vol. 106, No. 10, pp. 1626–1637
Publisher
Springer Nature
Publication Date
5 2012
DOI
10.1038/bjc.2012.147
ISSN
0007-0920